semaglutide with other medications for Weight Loss: How It Works, Comparisons, and More Novo Nordisk medicines containing semaglutide

Tirzepatide targets GLP-1 and GIP receptors, while retatrutide activates GLP-1, GIP, and glucagon receptors

If approved, it would represent a significant step above what tirzepatide currently offers particularly for patients with very high starting BMIs or those who have plateaued at maximum tirzepatide doses

When used with insulin or sulfonylureas, dose adjustments of these medications may be needed to reduce hypoglycemia risk

The thigh also usually has enough fatty tissue for proper subcutaneous injections, which means the medicine goes into the fat layer under the skin instead of deep into muscle

The Impact of GLP-1 Medications 2025 saw the further rise of a group of medicines called GLP-1s